Preface |
|
v | |
Contributors |
|
xi | |
Guide to the Companion CD |
|
xiii | |
|
Part I. Introduction to High Content Screening |
|
|
|
Past, Present, and Future of High Content Screening and the Field of Cellomics |
|
|
3 | (16) |
|
|
A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery |
|
|
19 | (14) |
|
|
|
Linking Microscopy and High Content Screening in Large-Scale Biomedical Research |
|
|
33 | (8) |
|
|
|
Part II. Instrumentation, Biological Application Software, and Sample Preparation |
|
|
|
Requirements, Features, and Performance of High Content Screening Platforms |
|
|
41 | (22) |
|
|
|
Characteristics and Value of Directed Algorithms in High Content Screening |
|
|
63 | (20) |
|
|
|
|
Characteristics and Value of Machine Learning for Imaging in High Content Screening |
|
|
83 | (12) |
|
|
Tools for Quantitative and Validated Measurements of Cells |
|
|
95 | (14) |
|
|
|
|
|
|
Automated Cell Plating and Sample Treatments for Fixed Cells in High Content Assays |
|
|
109 | (12) |
|
|
|
|
|
Differentiating Primary Human Cells in Rapid-Throughput Discovery Applications |
|
|
121 | (8) |
|
|
|
Use of the CellCard™ System for Analyzing Multiple Cell Types in Parallel |
|
|
129 | (12) |
|
|
|
|
|
|
Reagents to Measure and Manipulate Cell Functions |
|
|
141 | (24) |
|
|
|
|
Fluorescent Proteins and Engineered Cell Lines |
|
|
165 | (24) |
|
|
Optimizing the Integration of Immunoreagents and Fluorescent Probes for Multiplexed High Content Screening Assays |
|
|
189 | (6) |
|
|
The HaloTag™: A Novel Technology for Cell Imaging and Protein Analysis |
|
|
195 | (14) |
|
|
|
Protein Labeling With FlAsH and ReAsH |
|
|
209 | (12) |
|
|
|
|
Exploiting Network Biology to Improve Drug Discovery |
|
|
221 | (12) |
|
|
|
Physiocological Indicators of Cell Function |
|
|
233 | (12) |
|
|
|
The Use of siRNA to Validate Immunofluorescence Studies |
|
|
245 | (8) |
|
|
|
|
Caged Substrates Applied to High Content Screening: An Introduction With an Eye to the Future |
|
|
253 | (16) |
|
|
|
|
Part IV. Informatics and Bioinformatics |
|
|
|
Overview of Informatics for High Content Screening |
|
|
269 | (12) |
|
|
|
|
Large-Scale Data Management for High Content Screening |
|
|
281 | (12) |
|
|
An Integrated Biomedical Knowledge Extraction and Analysis Platform: Using Federated Search and Document Clustering Technology |
|
|
293 | (8) |
|
|
Visualization of High Content Screening Data |
|
|
301 | (18) |
|
|
Pathway Mapping Tools for Analysis of High Content Data Sean |
|
|
319 | (34) |
|
|
|
|
|
|
Part V. Assays and Applications of High Content Screening |
|
|
|
Systems Biology in Cancer Research: Genomics to Cellomics |
|
|
353 | (14) |
|
|
|
|
|
Target Validation in Drug Discovery |
|
|
367 | (12) |
|
|
High Content Screening as a Screening Tool in Drug Discovery |
|
|
379 | (10) |
|
|
Discovery of Protein Kinase Phosphatase Inhibitors |
|
|
389 | (12) |
|
|
|
High Content Translocation Assays for Pathway Profiling |
|
|
401 | (14) |
|
|
|
|
|
|
In Vitro Cytotoxicity Assessment |
|
|
415 | (12) |
|
|
|
Neurite Outgrowth in Retinal Ganglion Cell Culture |
|
|
427 | (8) |
|
|
Index |
|
435 | |